With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
Kailera Therapeutics is advancing a pipeline of obesity drugs, led by the GLP-1/GIP dual agonist ribupatide, which the ...
Kailera Therapeutics raised $625M in its IPO, ranking among the biggest ever biotech IPOs and surpassing Moderna's 2018 debut ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results